Research areas

Find within research areas:

348511 - 348520 out of 407,623Page size: 10
Sort by: 1st author
  1. Published

    Are ex vivo neutralising antibodies against IFN-beta always detrimental to therapeutic efficacy in multiple sclerosis?

    Sorensen, P. S., Koch-Henriksen, N. & Bendtzen, K., 1 Jun 2007, In: Multiple Sclerosis. 13, 5, p. 616-21 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS

    Sorensen, P. S., Petersen, T. T., Kahr Mathiesen, H., Langkilde, Annika Reynberg, Pedersen, Christian Ross, Ravnborg, M., Bendtzen, K., Solberg Sorensen, P., Tscherning, M., Langkilde, A., Ross, C. & Bendtzen, K., 2006, In: Neurology. 67, 9, p. 1681-83

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Appearance and disappearance of neutralizing antibodies during interferon-beta therapy

    Sorensen, P. S., Koch-Henriksen, N., Pedersen, Christian Ross, Clemmesen, K. M., Bendtzen, K. & Danish Multiple Sclerosis Study Group, D. M. S. S. G., 12 Jul 2005, In: Neurology. 65, 1, p. 33-9 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Oral fumarate for relapsing-remitting multiple sclerosis

    Sorensen, P. S. & Sellebjerg, Finn Thorup, 2008, In: Lancet. 372, 9648, p. 1447-1448 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    [Biological treatment of multiple sclerosis]

    Sorensen, P. S. & Sellebjerg, Finn Thorup, 2008, In: Ugeskrift for læger. 170, 24, p. 2156-2159 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study

    Sørensen, Per Soelberg, Lisby, S., Grove, R., Derosier, F., Shackelford, S., Havrdova, E., Drulovic, J. & Filippi, M., 18 Feb 2014, In: Neurology. 82, 7, p. 573-581 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    An update on combination therapies for multiple sclerosis: where are we now?

    Sørensen, Per Soelberg, Magyari, Melinda & Sellebjerg, Finn Thorup, 2023, In: Expert Review of Neurotherapeutics. 23, 12, p. 1173-1187 15 p.

    Research output: Contribution to journal › Review › Research › peer-review

  8. Published

    Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis

    Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 6, p. 569-589 21 p.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    New management algorithms in multiple sclerosis

    Sørensen, Per Soelberg, Jun 2014, In: Current Opinion in Neurology. 27, 3, p. 246-259 14 p.

    Research output: Contribution to journal › Review › Research › peer-review

  10. Published

    The window of opportunity for treatment of progressive multiple sclerosis

    Sørensen, Per Soelberg, Fox, R. J. & Comi, G., 2020, In: Current Opinion in Neurology. 33, 3, p. 262-270

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...34848 34849 34850 34851 34852 34853 34854 34855 ...40763 Next